热门资讯> 正文
MiNK Therapeutics重新与纳斯达克合规
2024-07-31 19:58
- MiNK Therapeutics (NASDAQ:INKT) said it has regained compliance with the Nasdaq Capital Market’s market value of listed securities requirement.
- Press Release
More on MiNK Therapeutics
- MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on MiNK Therapeutics
- Historical earnings data for MiNK Therapeutics
- Financial information for MiNK Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。